Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes

Wen Chin Ko, Chuang Ye Hong, Shaw Min Hou, Chien-Huang Lin, Eng Thiam Ong, Chwen Fang Lee, Chia Ti Tsai, Ling Ping Lai

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background: Atrial fibrosis is a feature of structural remodeling in atrial fibrillation (AF). Connective tissue growth factor (CTGF) is a potent profibrotic factor, but its role of CTGF in AF is not yet fully understood. Methods and Results: Right atrial appendages were obtained from 20 patients who underwent cardiac surgery (10 with sinus rhythm, 10 with AF). The mRNA level, protein level and immunohistochemical staining of CTGF were significantly increased in AF patients. In a porcine AF model, tissue angiotensin II (Ang II) and CTGF levels were significantly upregulated in both atria. In perfused rat hearts, Ang II stimulation increased CTGF expression, which could be inhibited by Ang II type I receptor antagonist. In a cell culture system, both atrial fibroblasts and myocytes were responsible for the increased CTGF expression under Ang II treatment. Ang II type I receptor antagonist could inhibit the Ang II-induced CTGF expression. Treating with recombinant CTGF, atrial fibroblasts expressed an increased level of collagen I. Furthermore, the CTGF level was highly correlated with tissue Ang II content in AF pigs. Conclusions: AF patients and animals exhibited a significantly increased expression of CTGF. Ang II stimulation upregulated CTGF expression in both atrial fibroblasts and myocytes. Ang II-induced CTGF expression might be involved in atrial substrate remodeling.

Original languageEnglish
Pages (from-to)1592-1600
Number of pages9
JournalCirculation Journal
Volume75
Issue number7
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Connective Tissue Growth Factor
Cardiac Myocytes
Angiotensin II
Atrial Fibrillation
Angiotensin I
Fibroblasts
Angiotensin Receptor Antagonists
Muscle Cells
human CTGF protein
Swine
Atrial Remodeling
Atrial Appendage
Thoracic Surgery

Keywords

  • Angiotensin ii
  • Atrial fibrillation
  • Connective tissue growth factor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes. / Ko, Wen Chin; Hong, Chuang Ye; Hou, Shaw Min; Lin, Chien-Huang; Ong, Eng Thiam; Lee, Chwen Fang; Tsai, Chia Ti; Lai, Ling Ping.

In: Circulation Journal, Vol. 75, No. 7, 07.2011, p. 1592-1600.

Research output: Contribution to journalArticle

Ko, Wen Chin ; Hong, Chuang Ye ; Hou, Shaw Min ; Lin, Chien-Huang ; Ong, Eng Thiam ; Lee, Chwen Fang ; Tsai, Chia Ti ; Lai, Ling Ping. / Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes. In: Circulation Journal. 2011 ; Vol. 75, No. 7. pp. 1592-1600.
@article{0fb722543ac64ff78d715d4dd222df78,
title = "Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes",
abstract = "Background: Atrial fibrosis is a feature of structural remodeling in atrial fibrillation (AF). Connective tissue growth factor (CTGF) is a potent profibrotic factor, but its role of CTGF in AF is not yet fully understood. Methods and Results: Right atrial appendages were obtained from 20 patients who underwent cardiac surgery (10 with sinus rhythm, 10 with AF). The mRNA level, protein level and immunohistochemical staining of CTGF were significantly increased in AF patients. In a porcine AF model, tissue angiotensin II (Ang II) and CTGF levels were significantly upregulated in both atria. In perfused rat hearts, Ang II stimulation increased CTGF expression, which could be inhibited by Ang II type I receptor antagonist. In a cell culture system, both atrial fibroblasts and myocytes were responsible for the increased CTGF expression under Ang II treatment. Ang II type I receptor antagonist could inhibit the Ang II-induced CTGF expression. Treating with recombinant CTGF, atrial fibroblasts expressed an increased level of collagen I. Furthermore, the CTGF level was highly correlated with tissue Ang II content in AF pigs. Conclusions: AF patients and animals exhibited a significantly increased expression of CTGF. Ang II stimulation upregulated CTGF expression in both atrial fibroblasts and myocytes. Ang II-induced CTGF expression might be involved in atrial substrate remodeling.",
keywords = "Angiotensin ii, Atrial fibrillation, Connective tissue growth factor",
author = "Ko, {Wen Chin} and Hong, {Chuang Ye} and Hou, {Shaw Min} and Chien-Huang Lin and Ong, {Eng Thiam} and Lee, {Chwen Fang} and Tsai, {Chia Ti} and Lai, {Ling Ping}",
year = "2011",
month = "7",
doi = "10.1253/circj.CJ-10-0892",
language = "English",
volume = "75",
pages = "1592--1600",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "7",

}

TY - JOUR

T1 - Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes

AU - Ko, Wen Chin

AU - Hong, Chuang Ye

AU - Hou, Shaw Min

AU - Lin, Chien-Huang

AU - Ong, Eng Thiam

AU - Lee, Chwen Fang

AU - Tsai, Chia Ti

AU - Lai, Ling Ping

PY - 2011/7

Y1 - 2011/7

N2 - Background: Atrial fibrosis is a feature of structural remodeling in atrial fibrillation (AF). Connective tissue growth factor (CTGF) is a potent profibrotic factor, but its role of CTGF in AF is not yet fully understood. Methods and Results: Right atrial appendages were obtained from 20 patients who underwent cardiac surgery (10 with sinus rhythm, 10 with AF). The mRNA level, protein level and immunohistochemical staining of CTGF were significantly increased in AF patients. In a porcine AF model, tissue angiotensin II (Ang II) and CTGF levels were significantly upregulated in both atria. In perfused rat hearts, Ang II stimulation increased CTGF expression, which could be inhibited by Ang II type I receptor antagonist. In a cell culture system, both atrial fibroblasts and myocytes were responsible for the increased CTGF expression under Ang II treatment. Ang II type I receptor antagonist could inhibit the Ang II-induced CTGF expression. Treating with recombinant CTGF, atrial fibroblasts expressed an increased level of collagen I. Furthermore, the CTGF level was highly correlated with tissue Ang II content in AF pigs. Conclusions: AF patients and animals exhibited a significantly increased expression of CTGF. Ang II stimulation upregulated CTGF expression in both atrial fibroblasts and myocytes. Ang II-induced CTGF expression might be involved in atrial substrate remodeling.

AB - Background: Atrial fibrosis is a feature of structural remodeling in atrial fibrillation (AF). Connective tissue growth factor (CTGF) is a potent profibrotic factor, but its role of CTGF in AF is not yet fully understood. Methods and Results: Right atrial appendages were obtained from 20 patients who underwent cardiac surgery (10 with sinus rhythm, 10 with AF). The mRNA level, protein level and immunohistochemical staining of CTGF were significantly increased in AF patients. In a porcine AF model, tissue angiotensin II (Ang II) and CTGF levels were significantly upregulated in both atria. In perfused rat hearts, Ang II stimulation increased CTGF expression, which could be inhibited by Ang II type I receptor antagonist. In a cell culture system, both atrial fibroblasts and myocytes were responsible for the increased CTGF expression under Ang II treatment. Ang II type I receptor antagonist could inhibit the Ang II-induced CTGF expression. Treating with recombinant CTGF, atrial fibroblasts expressed an increased level of collagen I. Furthermore, the CTGF level was highly correlated with tissue Ang II content in AF pigs. Conclusions: AF patients and animals exhibited a significantly increased expression of CTGF. Ang II stimulation upregulated CTGF expression in both atrial fibroblasts and myocytes. Ang II-induced CTGF expression might be involved in atrial substrate remodeling.

KW - Angiotensin ii

KW - Atrial fibrillation

KW - Connective tissue growth factor

UR - http://www.scopus.com/inward/record.url?scp=79959738377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959738377&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-10-0892

DO - 10.1253/circj.CJ-10-0892

M3 - Article

C2 - 21576830

AN - SCOPUS:79959738377

VL - 75

SP - 1592

EP - 1600

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 7

ER -